307 studies found for:    NIAID | Recruiting | Exclude Unknown
Show Display Options
Rank Status Study
21 Recruiting Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
Conditions: Tuberculosis;   Filariasis
Intervention:
22 Recruiting HIV Accelerated Liver Disease in Uganda
Condition: Fibrosis
Intervention:
23 Recruiting Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy
Conditions: Acquired Immune Deficiency Syndrome Virus;   Acquired Immunodeficiency Syndrome Virus;   AIDS Virus;   Human Immunodeficiency Virus;   Human Immunodeficiency Viruses
Intervention:
24 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:
25 Recruiting Treatment of Patients With Cysticercosis With Praziquantel or Albendazole
Condition: Cysticercosis
Intervention:
26 Recruiting Bone Marrow Stromal Cells for Inflammatory Bowel Diseases
Conditions: Crohns;   Ulcerative Colitis
Intervention: Procedure: Allogenic Bone Marrow Stromal Cell Inf
27 Recruiting Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
Conditions: CVID;   Enteropathy;   Chronic Diarrhea;   Maldigestion;   Malabsorption
Intervention: Biological: Ustekinumab
28 Recruiting Immune Regulation in Ulcerative Colitis or Crohn s Disease
Conditions: Crohn's Disease;   Inflammatory Bowel Disease;   Ulcerative Colitis
Intervention:
29 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
30 Recruiting Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous Disease
Conditions: Radiofrequency Ablation;   Liver Abscesses -Staphylococcus Infection;   CGD;   Chronic Granulomatous Disease;   RFA
Interventions: Procedure: RFA - Radiofrequency Ablation;   Procedure: Scans - Liver;   Procedure: Liver;   Procedure: Drawn
31 Recruiting A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
Condition: Eosinophilia
Intervention:
32 Recruiting Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases
Conditions: Occupational Accidents;   Incubation Period, Infectious Disese
Intervention:
33 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
34 Recruiting Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
Condition: Systemic Capillary Leak Syndrome
Intervention:
35 Recruiting Identification of Viruses Associated With Diseases of Unknown Cause
Condition: Viral Diseases
Intervention:
36 Recruiting A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection
Condition: Loiasis
Interventions: Drug: Reslizumab;   Drug: Diethylcarbamazine
37 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
38 Recruiting Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation
Conditions: Piebaldism;   Idiopathic Anaphylaxis;   Allergy;   Chronic Urticara;   Angioedema
Intervention:
39 Recruiting Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Interventions: Drug: Dexpramipexole;   Drug: Corticosteroid Taper
40 Recruiting Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Intervention: Drug: Imatinib Mesylate

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years